Lancashire (LRE) Competitors GBX 633 +6.00 (+0.96%) As of 11:45 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesBuy This Stock LRE vs. MDC, ROAD, CCT, GEO, PRIM, EME, CCS, PHM, J, and MTHShould you be buying Lancashire stock or one of its competitors? The main competitors of Lancashire include Mediclinic International (MDC), Roadside Real Estate (ROAD), The Character Group (CCT), Georgian Mining (GEO), Primorus Investments (PRIM), Empyrean Energy (EME), Crossword Cybersecurity (CCS), Phimedix Plc (PHM.L) (PHM), Jacobs Engineering Group (J), and Mithras Investment Trust (MTH). These companies are all part of the "construction" industry. Lancashire vs. Its Competitors Mediclinic International Roadside Real Estate The Character Group Georgian Mining Primorus Investments Empyrean Energy Crossword Cybersecurity Phimedix Plc (PHM.L) Jacobs Engineering Group Mithras Investment Trust Lancashire (LON:LRE) and Mediclinic International (LON:MDC) are both construction companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, profitability, risk, institutional ownership, dividends, media sentiment, valuation and earnings. Is LRE or MDC a better dividend stock? Lancashire pays an annual dividend of GBX 0.24 per share and has a dividend yield of 0.0%. Mediclinic International pays an annual dividend of GBX 3 per share. Lancashire pays out 25.9% of its earnings in the form of a dividend. Mediclinic International pays out 1,304.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Lancashire is clearly the better dividend stock, given its higher yield and lower payout ratio. Do institutionals and insiders hold more shares of LRE or MDC? 63.4% of Lancashire shares are held by institutional investors. Comparatively, 39.2% of Mediclinic International shares are held by institutional investors. 4.6% of Lancashire shares are held by company insiders. Comparatively, 48.9% of Mediclinic International shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has higher earnings and valuation, LRE or MDC? Lancashire has higher earnings, but lower revenue than Mediclinic International. Mediclinic International is trading at a lower price-to-earnings ratio than Lancashire, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLancashire£1.82B0.84£199.02M£0.92688.04Mediclinic International£3.38B0.00£169M£0.23N/A Does the media refer more to LRE or MDC? In the previous week, Lancashire had 1 more articles in the media than Mediclinic International. MarketBeat recorded 1 mentions for Lancashire and 0 mentions for Mediclinic International. Lancashire's average media sentiment score of 0.00 equaled Mediclinic International'saverage media sentiment score. Company Overall Sentiment Lancashire Neutral Mediclinic International Neutral Which has more risk and volatility, LRE or MDC? Lancashire has a beta of 0.62, suggesting that its share price is 38% less volatile than the S&P 500. Comparatively, Mediclinic International has a beta of 0.42, suggesting that its share price is 58% less volatile than the S&P 500. Do analysts recommend LRE or MDC? Lancashire presently has a consensus target price of GBX 690.25, suggesting a potential upside of 9.04%. Given Lancashire's stronger consensus rating and higher possible upside, research analysts clearly believe Lancashire is more favorable than Mediclinic International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lancashire 0 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.40Mediclinic International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is LRE or MDC more profitable? Lancashire has a net margin of 37.12% compared to Mediclinic International's net margin of 4.99%. Lancashire's return on equity of 10.76% beat Mediclinic International's return on equity.Company Net Margins Return on Equity Return on Assets Lancashire37.12% 10.76% 6.75% Mediclinic International 4.99%5.50%2.30% SummaryLancashire beats Mediclinic International on 13 of the 16 factors compared between the two stocks. Get Lancashire News Delivered to You Automatically Sign up to receive the latest news and ratings for LRE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LRE vs. The Competition Export to ExcelMetricLancashireInsurance IndustryFinancial SectorLON ExchangeMarket Cap£1.53B£2.66B£6.38B£2.57BDividend Yield2.92%2.22%4.31%5.31%P/E Ratio688.04468.441,784.315,424.41Price / Sales0.84172.651,356.9397,395.47Price / Cash2.172.04127.5227.93Price / Book1.031.682.089.35Net Income£199.02M£474.99M£1.23B£5.89B7 Day Performance4.80%2.75%1.03%0.45%1 Month Performance4.11%1.58%2.16%44.41%1 Year Performance-8.26%12.60%31.10%184.54% Lancashire Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LRELancashire2.8042 of 5 starsGBX 633+1.0%GBX 690.25+9.0%-7.9%£1.53B£1.82B688.04393High Trading VolumeMDCMediclinic InternationalN/AN/AN/AN/A£3.69B£3.38B2,178.261,640ROADRoadside Real EstateN/AGBX 54-0.5%N/A+164.0%£77.59M£590K196.223,790CCTThe Character GroupN/AGBX 296+0.7%N/A+2.7%£53.38M£118.82M1,004.751,540Dividend IncreaseGEOGeorgian MiningN/AGBX 0.44-1.3%N/A-75.0%£20.51MN/A-516.2815,800Gap UpHigh Trading VolumePRIMPrimorus InvestmentsN/AGBX 3.88-3.0%N/A+36.7%£4.94M£3.25M201.7712,800Gap DownEMEEmpyrean EnergyN/AGBX 0.06-4.8%N/A-81.5%£3.43MN/A-33.3335,500CCSCrossword CybersecurityN/AN/AN/AN/A£1.95M£4.19M-43.751,540Gap DownHigh Trading VolumePHMPhimedix Plc (PHM.L)N/AN/AN/AN/A£327KN/A-1.586,520Gap DownHigh Trading VolumeJJacobs Engineering GroupN/AN/AGBX 250+∞N/A£0.00N/A0.0060,000High Trading VolumeMTHMithras Investment TrustN/AN/AN/AN/A£0.00N/A0.001,920Gap Up Related Companies and Tools Related Companies Mediclinic International Competitors Roadside Real Estate Competitors The Character Group Competitors Georgian Mining Competitors Primorus Investments Competitors Empyrean Energy Competitors Crossword Cybersecurity Competitors Phimedix Plc (PHM.L) Competitors Jacobs Engineering Group Competitors Mithras Investment Trust Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:LRE) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lancashire Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Lancashire With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
